19 November 2018
In contrast to their non-metastatic counterparts, metastatic cancer cells show movement patterns that are also often employed by predators searching for prey. This was shown by an international study on movement patterns of cancer cells published in Nature Communications this month. Cell biologists from Radboud university medical center also participated in this study. The elimination of the ability of metastatic cells to execute such walks creates new opportunities to inhibit metastatic spread.
Microtracks
An international research team led by the Ulsan National Institute of Science and Technology in South Korea has studied the function of Lévy-like movement patterns in cancer cells. The team used microscopic slides in which microtracks had been etched. The width of these tracks was sufficient for one cell to freely move from left to right (video). The researchers studied the movements of both non-metastatic and metastatic breast, skin and prostate cancer cells. Only metastatic cells displayed movement patterns consistent with Lévy walks, i.e. an initial long excursion to the left or right, followed by a number of small steps back and forth, again followed by a long excursion. These patterns were not found in non-metastatic cells, which only made diffusive movements.Long excursion and small steps
The Lévy movement vaguely resembles the actions taken when searching for lost keys. Initially, you look closely at a particular spot, for instance your purse. Next, you leap toward another spot, e.g. the kitchen drawer, now closely searching this spot. This change between major targeted leaps and minor movements is typical of the Lévy walk. In the wild, e.g. when predators are searching for prey, this turns out to be a favorable approach with an optimal balance between effort and search results.3D collagen model
Although linear microtracks are found in living tissues, for instance along muscle fibers or collagen bundles, most tissues have a more complex three-dimensional structure. Therefore, researchers from Radboud university medical center studied the behavior of cancer cells by using a 3D collagen model. In this model, too, Lévy-like movement patterns were found in metastatic cancer cells. Although this 3D model is a better representation of the real-life situation, it does not take into account environmental factors. To measure the impact of these environmental factors on cell movements, the behavior of cancer cells was then studied in living tumors.Mouse
The researchers from Radboud university medical center studied both non-metastatic and metastatic melanoma cells in the skin of a mouse. Both types of cells were shown to spread by forcing hair-like dendrites into spaces between collagen, blood vessels, nerves and muscle cells. In this case, too, only metastatic cancer cells showed movements consistent with Lévy walks (video). These cells moved faster and more targetedly without being influenced by environmental factors. Apparently, this is the optimal movement strategy for cancer cells to quickly and targetedly find suitable loci to seed metastatic cancers.Weak spot
As the predatory movement appears to be an intrinsic property of metastatic cancer cells, it may be interesting to eliminate this ability. By doing so, tumor cells may be prevented from making predatory movements. As a result, metastatic spread may also be prevented. The researchers inhibited two proteins which need to collaborate in order for a cell to move in a targeted manner. Without these collaborating proteins, the Lévy walk was reverted into regular diffusive motions characterizing benign, non-metastatic cancer cells. Therefore, the Lévy walk could be the weak spot of cancer cells.Related news items
![](https://www.radboudumc.nl/getmedia/ec7e3d0b-827d-4a8d-84de-7bd0744836c1/Friedl,-Peter-uitsnede.aspx?width=2822&height=1693&ext=.png&type=BlockColumn1Zoom1)
NWO open call GROOT grant for Peter Friedl
24 February 2020 Peter Friedl, theme Cancer development and immune defense, received a 300,000 EUR grant within the NWO-GROOT consortium "Active matter of cancer metastasis" to identify the mechanisms of collective metastasis in breast cancer. read more![](https://www.radboudumc.nl/getmedia/ec7e3d0b-827d-4a8d-84de-7bd0744836c1/Friedl,-Peter-uitsnede.aspx?width=2822&height=1693&ext=.png&type=BlockColumn1Zoom1)
p120-catenin-dependent collective brain infiltration by glioma cell networks
7 January 2020 Pavlo Gritsenko and Peter Friedl, theme Cancer development and immune defense, report in Nature Cell Biology, that glioma cells infiltrate the brain by a collective network mechanism, which critically depends on p120 catenin. p120 thus represents a potential target to combat glioma. read more![](https://www.radboudumc.nl/getmedia/e40b4a60-e54d-4b8f-8a1f-236b415d11ae/Anna-en-Peter.aspx?width=275&height=165&ext=.png&type=BlockColumn1Zoom1)
Collective cancer invasion forms an integrin-dependent radioresistant niche
29 October 2019 Anna Häger and Peter Friedl, theme Cancer development and immune defense, identified a new niche of cancer cell survival and developed an integrin inhibition therapy to overcome resistance. They have published their results in JEM. read more![](https://www.radboudumc.nl/getmedia/c06d74f7-d16e-417d-9bf6-4217122b262b/NWO-vidi.aspx?width=270&height=162&ext=.png&type=BlockColumn1Zoom1)
Three VIDI grants for RIMLS researchers
24 May 2019 Matthijs Jore, Daniele Tauriello and Johannes Textor are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO is awarding the Vidi grant as part of the Innovational Research Incentives Scheme. read more![](https://www.radboudumc.nl/getmedia/95fe9baa-00c1-4b9b-a4f9-4b7033787bcb/New-years-drinks-2019.aspx?width=855&height=513&ext=.jpg&type=BlockColumn1Zoom1)
RIMLS awards festival Twelve winners
16 January 2019 In 5 categories RIMLS young researchers received an award and bonus during the New Year's drinks. See all photo's. read more![](https://www.radboudumc.nl/getmedia/f3c27991-48c9-455f-9572-88aa736d0512/Turbo-grants-2018.aspx?width=395&height=237&ext=.png&type=BlockColumn1Zoom1)